New hope for kids with arthritis: drug trial launches
NCT ID NCT06668181
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study tests a drug called bimekizumab in children aged 2 to 17 with specific types of juvenile arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis). The goal is to see how the drug moves through the body and if it is safe. About 40 children will take part, receiving the drug as a shot under the skin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTHESITIS RELATED ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ja0005 40072
RECRUITINGFreiburg im Breisgau, Germany
-
Ja0005 40100
RECRUITINGMadrid, Spain
-
Ja0005 40356
RECRUITINGDresden, Germany
-
Ja0005 40369
RECRUITINGBerlin, Germany
-
Ja0005 40427
RECRUITINGTübingen, Germany
-
Ja0005 40510
RECRUITINGLe Kremlin-Bicêtre, France
-
Ja0005 40720
RECRUITINGKrakow, Poland
-
Ja0005 40776
RECRUITINGPoitiers, France
-
Ja0005 40777
RECRUITINGIndre-et-Loire, France
-
Ja0005 40778
RECRUITINGParis, France
-
Ja0005 40779
RECRUITINGSendenhorst, Germany
-
Ja0005 40780
RECRUITINGSosnowiec, Poland
-
Ja0005 40781
RECRUITINGEsplugues de Llobregat, Spain
-
Ja0005 40782
RECRUITINGValencia, Spain
-
Ja0005 40783
RECRUITINGManchester, United Kingdom
-
Ja0005 40784
ACTIVE_NOT_RECRUITINGStroke-on-trent, United Kingdom
-
Ja0005 40785
RECRUITINGNottingham, United Kingdom
-
Ja0005 40786
RECRUITINGBristol, United Kingdom
-
Ja0005 40787
RECRUITINGSankt Augustin, Germany
-
Ja0005 40852
RECRUITINGHamburg, Germany
-
Ja0005 50644
RECRUITINGMontreal, Canada
-
Ja0005 50645
RECRUITINGSaskatoon, Canada
-
Ja0005 50646
RECRUITINGCalgary, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a biologic drug tame juvenile arthritis in kids?
- New hope for kids with arthritis: drug trial shows promise
- Coaching eases tough move to adult rheumatology care
- New hope for kids with joint pain: risankizumab trial launches
- New drug trial aims to control arthritis in kids
- New study checks safety of apremilast for kids with painful mouth sores and arthritis